CDTX vs DOW · rev $1.3M vs P/E 74, rev $42.96B
Cidara Therapeutics Inc (CDTX) versus Dow Inc (DOW) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Dow Inc (DOW) is a chemicals company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
CDTX currently screens at market cap $6.96B. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Not investment advice. Open the CDTX and DOW stock pages for the full models.
Not investment advice.